EGFR and non-small cell lung carcinoma: To determine the optimal management of patients with EGFR-mutant NSCLC with brain metastases, this study investigated the clinical outcomes according to the use of upfront RT (WBRT or SRS) as well as the disease progression pattern and subsequent therapy following intracranial progression.